Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Heterogeneous nuclear ribonucleoproteins depict a new predictive risk model for ovarian cancer prognosis and immunotherapy
Related
- Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
- Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC
- Predictive value of cardiac magnetic resonance atrial and ventricular strain for adverse prognosis in patients with myocarditis: a systematic review and meta-analysis
- Assessment of predictive efficacy for prognosis of pediatric severe Mycoplasma pneumoniae pneumonia: a comprehensive study based on high-resolution computed tomography imaging and platelet parameters
- Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy—A Reanalysis of OAK and POPLAR
BibTeX
@article{hu2026heterogeneous,
title = {{Heterogeneous nuclear ribonucleoproteins depict a new predictive risk model for ovarian cancer prognosis and immunotherapy}},
author = {Dongzhi Hu and Shifan Ren and Yongjing Zhang and Xiaoxue Li and Zijian Zhang},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74225-9},
url = {https://www.nature.com/articles/s41598-026-74225-9},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Heterogeneous nuclear ribonucleoproteins depict a new predictive risk model for ovarian cancer prognosis and immunotherapy
AU - Dongzhi Hu
AU - Shifan Ren
AU - Yongjing Zhang
AU - Xiaoxue Li
AU - Zijian Zhang
PY - 2026
DA - 2026/10/14
JO - Scientific Reports
DO - 10.1038/s41598-026-74225-9
UR - https://www.nature.com/articles/s41598-026-74225-9
SN - 2045-2322
ER -